Abstract:
The present disclosure describes a composition and a kit having a plurality of compounds for use in the treatment of inflammatory joint diseases and chronic inflammatory connective tissue diseases, such as Rheumatoid Arthritis (RA). The disclosure also relates to a process of obtaining the composition and the method of treating diseases by administration of the compositions.
Abstract:
The present invention describes a composition and a kit, each having a plurality of compounds, for use in the treatment of inflammatory joint diseases and chronic inflammatory connective tissue diseases, such as Rheumatoid Arthritis (RA). The invention also relates to a process of obtaining the composition and a method of treating diseases by administration of the compositions.
Abstract:
A business-to-business application service provider includes an Internet website and webserver with EDA-on-demand solutions for system-on-a-chip designers. Such website allows electronic designs in hardware description language to be uploaded into a front-end EDA design environment. A behavioral model simulation tool hosted privately on the webserver tests and validates the design. Such tool executes only in the secure environment of the business-to-business application service provider. The validated solution is then downloaded back over the Internet for a pay-per-use fee to the customer, and in a form ready to be placed and routed by a back-end EDA tool. Such validated design solutions are also downloadable to others in exchange for other designs, or available in technology libraries. The intellectual property created can be re-used, sold, shared, exchanged, and otherwise distributed efficiently and easily from a central for-profit clearinghouse.